Viasat Inc: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 9, 2024 and accepted by EDGAR at Feb 9, 2024, 02:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-04-01 to 2023-12-31 | $3.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2023-10-01 to 2023-12-31 | $41.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-04-01 to 2023-12-31 | $104.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $271.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-04-01 to 2023-12-31 | $1.64bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | −$43.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-04-01 to 2023-12-31 | −$890.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $133.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-04-01 to 2023-12-31 | $275.6m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | −$34.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-04-01 to 2023-12-31 | −$128.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | −$124.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-04-01 to 2023-12-31 | −$968.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | −$0.99 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-04-01 to 2023-12-31 | −$8.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | −$0.99 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-04-01 to 2023-12-31 | −$8.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 125,097,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-04-01 to 2023-12-31 | 114,317,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-04-01 to 2023-12-31 | $456.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2023-12-31 | $1.62bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $3.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $16.65bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $1.38bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $11.50bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-12-31 | $62.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $5.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-013013. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.